Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha

Updated on: January 02,2024

Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha

Updated on:January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on: April 22,2024

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on:April 22,2024

Improving health outcomes with a little help from our friends—and artificial intelligence

by Medical University of South CarolinaDr. Chanita Hughes-Halbert of the Medical University of South Carolina and Hollings Cancer Center studies social determinants of health and health dispariti

Updated on: April 22,2024

Improving health outcomes with a little help from our friends—and artificial intelligence

by Medical University of South CarolinaDr. Chanita Hughes-Halbert of the Medical University of South Carolina and Hollings Cancer Center studies social determinants of health and health dispariti

Updated on:April 22,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on: February 01,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on:February 01,2024

Financial toxicity of cancer impacts partners' quality of life, says study

by Nicole Fawcett,University of MichiganAssociations Between Health-Related Quality of Life Domains and Financial Toxicity Outcomes. Credit:JAMA Network Open(2023). DOI: 10.1001/jama

Updated on: January 16,2024

Financial toxicity of cancer impacts partners' quality of life, says study

by Nicole Fawcett,University of MichiganAssociations Between Health-Related Quality of Life Domains and Financial Toxicity Outcomes. Credit:JAMA Network Open(2023). DOI: 10.1001/jama

Updated on:January 16,2024

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Updated on: February 03,2024

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Updated on:February 03,2024

Researchers suggest rethinking 'cancer' label for early-stage prostate changes

byOxford University PressCredit: CC0 Public DomainA new paper in theJournal of the National Cancer Instituteindicates that patients may benefit if doctors stop calling certain early-

Updated on: November 10,2024

Researchers suggest rethinking 'cancer' label for early-stage prostate changes

byOxford University PressCredit: CC0 Public DomainA new paper in theJournal of the National Cancer Instituteindicates that patients may benefit if doctors stop calling certain early-

Updated on:November 10,2024

Research points to potential new treatment for aggressive prostate cancer subtype

byUniversity of MichiganProstate cancer cells. Credit: NIH Image GalleryWhen researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate c

Updated on: November 11,2024

Research points to potential new treatment for aggressive prostate cancer subtype

byUniversity of MichiganProstate cancer cells. Credit: NIH Image GalleryWhen researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate c

Updated on:November 11,2024

Predicting cancer versus autism risk in PTEN patients

by Cleveland ClinicIn a newly published study, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may p

Updated on: May 07,2024

Predicting cancer versus autism risk in PTEN patients

by Cleveland ClinicIn a newly published study, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may p

Updated on:May 07,2024

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

Updated on: January 29,2024

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

Updated on:January 29,2024

New treatment could be advance against cervical precancers

by Ernie MundellWomen who undergo regular Pap smears are no doubt familiar with the possibility of "precancerous" cells being detected.These cells—called cervical intraepithelial neoplasias

Updated on: April 28,2024

New treatment could be advance against cervical precancers

by Ernie MundellWomen who undergo regular Pap smears are no doubt familiar with the possibility of "precancerous" cells being detected.These cells—called cervical intraepithelial neoplasias

Updated on:April 28,2024